Wegovy is approved for weight loss by the U.S. Food and Drug Administration, while Ozempic is not, though many people are using it off-label for that purpose.
the side effects were so severe they stopped taking the drugs or questioned whether they could stay on them long-term.
Because Ozempic is not approved for weight loss, it wasn’t studied for “weight changes following discontinuation,” Novo NordiskData from its clinical trials for Wegovy"showed that, not unexpectedly, patients experience weight regain once they stop taking the medication,” the company previously said in a“This supports the belief that obesity is a chronic disease that requires long-term management, much like high blood pressure or high cholesterol, for which most patients remain on therapy...
Dr. Robert Lustig, a neuroendocrinologist and professor emeritus of pediatrics at the University of California, San Francisco,he has “major, major concerns” about people potentially taking Wegovy for years or for life. He’s not against the drug, but calls it a Band-Aid that’s not fixing the root of the problem of obesity.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Novo Nordisk's diabetes drug Ozempic back in supply in US after months of shortageNovo Nordisk's best-selling diabetes treatment drug Ozempic is back on the shelves in the United States after months of shortage, the U.S. Food and Drug Administration (FDA) website showed on Friday.
Lire la suite »
TikTok's Fave Weight Loss Drugs: Link to Thyroid Cancer?Demand for Ozempic continues to surge, fueled by social media; but research suggests that for some, use of these injectables may be linked to increased risk for thyroid cancer.
Lire la suite »
Ozempic prescriptions can be easy to get online. Its popularity for weight loss is hurting those who need it most | CNNTelehealth and social media are playing a significant role in driving demand for Ozempic, a prescription drug that treats Type 2 diabetes, experts told CNN. The current drug shortage has limited access for patients with diabetes who rely on it to control their blood sugar.
Lire la suite »
Bain Capital's Connaughton says SVB fallout will weigh on banksBain Capital's co-managing partner John Connaughton told Reuters that the banking sector is strong enough to withstand SVB's failure despite a ‘period of disorientation’ over the U.S. Federal Reserve's aggressive rate hike
Lire la suite »
Neighbors weigh in on the step forward for future redevelopment of Brookville Road-Irvington PlazaOn Monday, the Metropolitan & Economic Development Committee unanimously approved a proposal that could help redevelop the area known as Brookville Road-Irvington Plaza.
Lire la suite »